Exercise capacity · people with pulmonary hypertension
1 finding from 1 review
BPD at 28 days · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes BPD defined as an oxygen requirement at 28 days№ of participants:… compared with placebo (very low certainty).
1 finding from 1 review
RR 1.09 [0.94, 1.26]
Studies not reported
Very low
Bronchopulmonary dysplasia · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes BPD defined as oxygen at 36 weeks' postmenstrual age№ of… compared with placebo (very low certainty).
1 finding from 1 review
RR 0.96 [0.72, 1.29]
Studies not reported
Very low
Need for supplemental oxygen (days)№ of participants: 0 (0 RCTs) · preterm infants at risk for bronchopulmonary dysplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
OXYGEN SATURATION DURING intervention (higher = favourable) · preterm infants and their parents
1 finding from 1 review
Intervention not reported
OXYGEN SATURATION POST‐intervention (higher = favourable) · preterm infants and their parents
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · preterm infants at risk for apnea
Methylxanthine probably leads to lower supplemental oxygen at 36 weeks' postmenstrual age compared with placebo or control (moderate certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · preterm infants with apnea
Methylxanthine probably leads to lower supplemental oxygen at 36 weeks' postmenstrual age compared with placebo or control (moderate certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · preterm infants prior to extubation
Methylxanthine probably leads to lower supplemental oxygen at 36 weeks' postmenstrual age compared with placebo or control (moderate certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · preterm infants at risk of or with apnea; preterm infants undergoing extubation
Methylxanthine leads to lower supplemental oxygen at 36 weeks' postmenstrual age compared with placebo or control (high certainty).
1 finding from 1 review
Chronic lung disease · treatment of apnea
The review found no eligible studies for this question.
3 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia/chronic lung disease · preterm infants
Caffeine showed no clear difference in bronchopulmonary dysplasia/chronic lung disease: defined as 28 days… compared with other methylxanthines (low certainty).
1 finding from 1 review
RR 1.4 [0.92, 2.11]
Studies not reported
Low
Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
1 finding from 1 review
Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oxygenation index (FiO2% X MPAW/PaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
1 finding from 1 review
Oxygen saturation (SaO2) ‐ not reported · acute respiratory distress in hospitalised infants and children
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found